Clinical Trial Update: Zoledronic Acid Combined With EC-T for Triple-Negative Breast Cancer [NA]

View source ↗

Summary

Clinical trial update on zoledronic acid combined with the EC-T chemotherapy regimen for metastatic triple-negative breast cancer; the study is currently active…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Triple-negative Breast Cancer

Drugs mentioned

• EC-T regimen
• Zoledronic acid (Zoledronic acid)

Snippet

Sponsor: Xijing Hospital | Conditions: Breast Cancer Metastatic | NA | Status: ACTIVE_NOT_RECRUITING